XML 25 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Note 7 - Shareholders' Equity
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Shareholders' Equity and Share-based Payments [Text Block]
7.
Shareholders' Equity
 
Equity Compensation Plans
 
We have a stock plan (the “Stock Plan”) and an inducement stock plan for newly hired employees (together with the Stock Plan, the “Plans”). Under the Plans, stock options to purchase shares of our common stock
may
be granted with a fixed exercise price that is equal to the fair market value of our common stock on the date of grant. These options have a term of up to
10
 years and vest over a predetermined period, generally
four
years. Incentive stock options granted under the Stock Plan
may
only be granted to our employees. The Plans also allow for awards of non-qualified stock options, stock appreciation rights, restricted and unrestricted stock awards, and restricted stock units (“RSUs”).
 
Stock-Based Compensation
 
The estimated fair value of stock-based awards is recognized as compensation expense over the vesting period of the award, net of estimated forfeitures. We estimate forfeitures based on historical experience and expected future activities. The fair value of RSUs is determined based on the number of shares granted and the quoted price of our common stock on the date of grant. The fair value of stock option awards is estimated at the grant date based on the fair value of each vesting tranche as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. The BSM model requires various highly judgmental assumptions including expected volatility and option life. If any of the assumptions used in the BSM model change significantly, stock-based compensation expense
may
differ materially in the future from that recorded in the current period. The fair values of our stock option grants were estimated with the following weighted average assumptions:
 
   
Three Months Ended September 30,
   
 Nine Months Ended September 30,
 
   
2020
   
2019
   
2020
   
2019
 
Dividend yield
   
0
%    
0
%    
0
%    
0
%
Expected life (years)
   
4.9
     
5.6
     
4.9
     
5.8
 
Expected volatility
   
63
%    
64
%    
63
%    
64
%
Risk-free interest rate
   
0.2
%    
1.6
%    
0.5
%    
2.1
%
 
The impact on our results of operations from stock-based compensation expense was as follows (in thousands, except per share amounts):
 
   
Three Months Ended September 30,
   
 Nine Months Ended September 30,
 
   
2020
   
2019
   
2020
   
2019
 
Cost of revenue — Edge to Cloud
  $
26
    $
1
    $
50
    $
10
 
Selling, general and administrative
   
250
     
175
     
536
     
373
 
Research and development
   
5
     
12
     
15
     
(12
)
Total stock-based compensation expense
  $
281
    $
188
    $
601
    $
371
 
 
Stock Option Activity
 
The following table summarizes stock option activity under the Plans:
 
     
 
 
   
 
 
 
Weighted
     
 
 
     
 
 
   
 
 
 
Average
     
 
 
     
 
 
 
Weighted
 
 
Remaining
     
 
 
     
 
 
 
Average
   
Contractual
   
Aggregate
 
   
Number of
   
Exercise
   
Life
   
Intrinsic
 
   
Shares
   
Price
   
(in years)
   
Value
 
Balance at December 31, 2019
   
1,544,826
    $
2.74
     
7.47
    $
46,582
 
Granted
   
574,900
     
1.03
     
 
     
 
 
Exercised
   
(25,000
)    
1.35
     
 
     
 
 
Forfeited
   
(109,656
)    
1.72
     
 
     
 
 
Expired
   
(200,367
)    
4.82
     
 
     
 
 
Balance at September 30, 2020
   
1,784,703
     
2.07
     
8.03
     
214,529
 
Vested and expected to vest at September 30, 2020
   
1,548,348
     
2.14
     
7.90
     
172,230
 
Exercisable at September 30, 2020
   
568,073
    $
3.35
     
6.28
    $
6,601
 
 
At
September 30, 2020
, total compensation cost related to stock options granted but
not
yet recognized, net of estimated forfeitures, was
$490,778.
This cost will be amortized on the straight-line method over a weighted-average period of approximately
1.6
years. The following table summarizes certain information about stock options:
 
   
Three Months Ended September 30,
   
 Nine Months Ended September 30,
 
   
2020
   
2019
   
2020
   
2019
 
Weighted average grant-date fair value of options granted during the period
  $
1.37
    $
1.23
    $
1.03
    $
1.70
 
Options in-the-money (in shares)
   
59,201
     
     
59,201
     
 
Aggregate intrinsic value of options exercised during the period
  $
1.35
    $
    $
1.35
    $
 
 
The aggregate intrinsic value represents the difference between the exercise price of the underlying options and the quoted price of our common stock for the number of options exercised during the period. We issue new shares of common stock upon exercise of stock options.
 
Restricted Stock Unit Activity
 
The following table summarizes RSU activity under the Plans:
 
   
Number of
   
Weighted Average
 
   
Shares
   
Award Price
 
Unvested at December 31, 2019
   
112,846
    $
1.44
 
Granted
   
219,596
     
1
 
Vested
   
(112,846
)    
1.44
 
Forfeited
   
     
 
Unvested at September 30, 2020
   
219,596
    $
1.48
 
Expected to vest after September 30, 2020
   
206,673
    $
1.48
 
 
At
September 30, 2020
, total compensation cost related to RSUs granted but
not
yet recognized, net of estimated forfeitures, was
$173,000.
This cost will be amortized on the straight-line method over a weighted-average period of approximately
0.4
years.
 
Common Stock Reserved for Future Issuance
 
The following table summarizes our shares of common stock reserved for future issuance under the Plans as of
September 30, 2020
:
 
   
September 30, 2020
 
Stock options outstanding
   
1,784,703
 
Restricted stock units outstanding
   
219,596
 
Stock options and restricted stock units available for future grant
   
1,245,563
 
Common stock reserved for future issuance
   
3,249,862